NIH-funded research R21 grant

New treatments for childhood obesity using dual hormone therapies

Official title: Efficacy of Novel Melanocortin and Gut-peptide Dual Agonists for Childhood Obesity Treatment

Funded at Seattle Children's Hospital · NIH-11056615 · Data updated 2026-11-12

This study is looking at new ways to help kids and teens with obesity by creating special treatments that can help them feel less hungry and lose weight, all while being easier on their bodies than current options.

More Obesity research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionSeattle Children's Hospital
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 19, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$531,174
NIH project number1R21HD115119-01A1
Project IDNIH-11056615 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children and adolescents struggling with obesity who may benefit from new treatment options.

Less likely to help

Patients who are not experiencing obesity or those with conditions that contraindicate the use of hormonal therapies may not benefit from this research.

What this research studies

This research investigates innovative treatments for childhood obesity by developing dual agonists that target both melanocortin and gut peptides. These therapies aim to suppress appetite and promote weight loss while minimizing side effects commonly associated with existing treatments. The approach focuses on enhancing energy expenditure and improving compliance among children and adolescents who struggle with obesity. By combining multiple mechanisms, the research seeks to provide a more effective and tolerable solution for young patients.

Why it matters

Potential benefit: If successful, this research could lead to more effective and safer weight loss treatments for children and adolescents with obesity.

How similar studies have gone: Previous research has shown promise in using hormonal therapies for obesity treatment, indicating that this approach may lead to significant advancements.

Where this research is happening

  • Seattle Children's Hospital
    Seattle, United States
    Active

Researchers

  • Principal investigator: Roth, Christian Ludwig — Seattle Children's Hospital
  • Study coordinator: Roth, Christian Ludwig

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.